A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

NCT00665457 ·Status: TERMINATED ·Phase: PHASE2

Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer

NCT04081389 ·Status: COMPLETED ·Phase: PHASE1

Phase II Study of Curcumin vs Placebo for Chemotherapy-Treated Breast Cancer Patients Undergoing Radiotherapy

NCT01740323 ·Status: COMPLETED ·Phase: PHASE2

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

NCT00524303 ·Status: COMPLETED ·Phase: PHASE2

Evaluate Trastuzumab Plus Standard Chemotherapy Given Before Surgery in Breast Cancer Patients With Low HER 2 Expression

NCT00944047 ·Status: COMPLETED ·Phase: PHASE2

Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45

NCT00914043 ·Status: WITHDRAWN

Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer

NCT05020860 ·Status: RECRUITING ·Phase: PHASE2

Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

NCT00353483 ·Status: RECRUITING

Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice

NCT04297384 ·Status: COMPLETED ·Phase: NA

Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling

NCT03412643 ·Status: UNKNOWN ·Phase: PHASE2

Prevention of Female Cancers by Optimization of Selenium Levels in the Organism.

NCT04014283 ·Status: UNKNOWN ·Phase: NA

Neoadjuvant Chemotherapy Including Sorafenib in Women With Previously Untreated Primary Breast Cancer

NCT00548899 ·Status: COMPLETED ·Phase: PHASE2

The Impact of the Gene Recurrence Score on Chemotherapy Prescribing in ER Positive, Lymph Node Positive Early Stage Breast Cancer

NCT03843346 ·Status: COMPLETED

Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer

NCT02032823 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer

NCT03628066 ·Status: COMPLETED ·Phase: PHASE2

Study of Tissue Samples From Women Treated With Paclitaxel for Breast Cancer on Clinical Trial CALGB-9344 or CALGB-9741

NCT00991263 ·Status: COMPLETED

Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers

NCT03911973 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Study to Learn About How Medicines Called CDK4/6 Inhibitors Are Used in People With Advanced or Metastatic Breast Cancer in Australia

NCT06624020 ·Status: COMPLETED

Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients

NCT00432172 ·Status: COMPLETED ·Phase: PHASE2

Docetaxel, Carboplatin, and Capecitabine as Treatment for Patients With Locally Advanced or Inflammatory Breast Cancer Before Surgery

NCT00251329 ·Status: UNKNOWN ·Phase: PHASE2

S9719 Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer

NCT00003095 ·Status: COMPLETED

Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009

NCT05134922 ·Status: AVAILABLE

Bryostatin 1 in Treating Patients With Stage IV Breast Cancer

NCT00003205 ·Status: COMPLETED ·Phase: PHASE2

Studying Tissue Samples From Women Who Underwent Chemotherapy for Lymph Node-Positive Stage II or Stage IIIA Breast Cancer on Clinical Trial CLB-9741 or CLB-9344

NCT00897026 ·Status: COMPLETED

Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

NCT00003953 ·Status: COMPLETED ·Phase: PHASE2